Menstrual and reproductive issues in adolescents with physical and developmental disabilities

Obstetrics and Gynecology

Volumn 124, Issue 2 PART1, 2014, Pages 367-375

  Quint, Elisabeth H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CHILD ABUSE, SEXUAL; COGNITION DISORDERS; CONTRACEPTIVE AGENTS, FEMALE; DEVELOPMENTAL DISABILITIES; FEMALE; GYNECOLOGICAL EXAMINATION; GYNECOLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICAL HISTORY TAKING; MENSTRUAL CYCLE; MENSTRUATION DISTURBANCES; PUBERTY; SELF EFFICACY; SEXUAL BEHAVIOR;

EID: 84905106415     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000387     Document Type: Article

References (41)

1. Kirkham YA, Allen L, Kives S, Caccia N, Spitzer RF, Ornstein MP. Trends in menstrual concerns and suppression in adolescents with developmental disabilities. J Adolesc Health 2013;53:407-12.
2. Shah P, Norlin C, Logsdon V, Samson-Fang L. Gynecological care for adolescents with disability: physician comfort, perceived barriers, and potential solutions. J Pediatr Adolesc Gynecol 2005; 18:101-4.
3. Americans with disabilities 2010. Report issued in July 2102. Available at: http://www.census.gov/prod/2012pubs/p70-131. pdf. Retrieved August 2013.
4. Zacharin M. Endocrine problems in children and adolescents who have disabilities. Horm Res Paediatr 2013;80:221-8.
5. Quint EH. Menstrual issues in adolescents with physical and developmental disabilities. Ann N Y Acad Sci 2008;1135:230-6.
6. Mitra M, Mouradian VE, McKenna M. Dating violence and associated health risks among high school students with disabilities. Matern Child Health J 2013;17:1088-94.
7. American College of Obstetricians and Gynecologists. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. ACOG Committee Opinion No. 349. Obstet Gy-necol 2006; 108: 1323-8.
8. Gomez MT, Carlson GM, Van Dooren K. Practical approaches to supporting young women with intellectual disabilities and high support needs with their menstruation. Health Care Women Int 2012;33:678-94.
9. Burke LM, Kalpakjian CZ, Smith YR, Quint EH. Gynecologic issues of adolescents with Down syndrome, autism, and cerebral palsy. J Pediatr Adolesc Gynecol 2010;23:11-5.
10. American College of Obstetricians and Gynecologists. Menstrual manipulation for adolescents with disabilities. ACOG Committee Opinion No. 448. Obstet Gynecol 2009; 114: 1428-31.
11. Lethaby A, Duckitt K, Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. The Co-chrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD000400. DOI: 10.1002/14651858.CD000400.pub3.
12. Leminen H, Hurskainen R. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health 2012;4:413-21.
13. Jacobson JC, Likis FE, Murphy PA. Extended and continuous combined contraceptive regimens for menstrual suppression. J Midwifery Womens Health 2012;57:585-92.
14. Gold MA, Duffy K. Extended cycling or continuous use of hormonal contraceptives for female adolescents. Curr Opin Obstet Gynecol 2009;21:407-11.
15. Lopez LM, Grimes DA, Gallo MF, Stockton LL, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. The Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD003552. DOI: 10.1002/14651858. CD003552.pub4.
16. Lidegaard Ø, Milsom I, Geirsson RT, Skjeldestad FE. Hormonal contraception and venous thromboembolism. Acta Obstet Gynecol Scand 2012;91:769-78.
17. Sulak PJ, Smith V, Coffee A, Witt I, Kuehl AL, Kuehl TJ. Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial. Obstet Gynecol 2008;112:563-71.
18. American College of Obstetricians and Gynecologists. Management of abnormal uterine bleeding associated with ovulatory dysfunction. Practice Bulletin No. 136. Obstet Gynecol 2013; 122: 176-85.
19. Ott MA, Shew ML, Ofner S, Tu W, Fortenberry JD. The influence of hormonal contraception on mood and sexual interest among adolescents. Arch Sex Behav 2008;37:605-13.
20. Hubacher D, Lopez L, Steiner MJ, Dorflinger L. Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Contraception 2009;80:113-8.
21. Arias RD, Jain JK, Brucker C, Ross D, Ray A. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg. Contraception 2006;74:234-8.
22. Lopez LM, Edelman A, Chen M, Otterness C, Trussell J, Helmerhorst FM. Progestin-only contraceptives: effects on weight. The Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD008815. DOI: 10.1002/14651858. CD008815.pub3.
23. Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, et al. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception 2010;81:281-91.
24. American College of Obstetricians and Gynecologists. Depot medroxyprogesterone acetate and bone effects. ACOG Committee Opinion No. 415. Obstet Gynecol 2008; 112: 727-30.
25. Lopez LM, Chen M, Mullins S, Curtis KM, Helmerhorst FM. Steroidal contraceptives and bone fractures in women: evidence from observational studies. The Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No.: CD009849. DOI: 10. 1002/14651858.CD009849.pub2.
26. Centers for Disease Control. Medical eligibility criteria contraceptive use, 2010. Adapted from the WHO medical eligibility criteria for contraceptive use. 4th ed. Atlanta (GA): Centers for Disease Control and Prevention; 2010.
27. American College of Obstetricians and Gynecologists. Adolescents and long-acting reversible contraception: implants and intrauterine devices. Committee Opinion No. 539. Obstet Gy-necol 2012; 120: 983-8.
28. Stoegerer-Hecher E, Kirchengast S, Huber JC, Hartmann B. Amenorrhea and BMI as independent determinants of patient satisfaction in LNG-IUD users: cross-sectional study in a Central European district. Gynecol Endocrinol 2012;28:119-24.
29. Hillard PJ. Menstrual suppression with the levonorgestrel intra-uterine system in girls with developmental delay. J Pediatr Ado-lesc Gynecol 2012;25:308-13.
30. Pillai M, O'Brien K, Hill E. The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities. BJOG 2010;117:216-21.
31. Daniels JP. The long-term outcomes of endometrial ablation in the treatment of heavy menstrual bleeding. Curr Opin Obstet Gynecol 2013;25:320-6.
32. Atkinson E, Bennett MJ, Dudley J, Matthews K, Moore P, Quinlivan J, et al. Consensus statement: Menstrual and contraceptive management in women with an intellectual disability. Aust N Z J Obstet Gynaecol 2003;43:109-10.
33. American College of Obstetricians and Gynecologists. Reproductive health care for adolescents with disabilities (supplement to Guidelines for adolescent health care, second edition). Available at: http://www.acog.org/Resources-And- Publications/Guidelines-for-Adolescent-Health-Care/Reprod uctive-Health-Care- for-Adolescents-With-Disabilities. Retrieved December 20, 2013.
34. Quint EH, Elkins TE, Sorg CA, Kope S. The treatment of cyclical behavioral changes in women with mental disabilities. J Pediatr Adolesc Gynecol 1999;12:139-42.
35. Nevatte T, O'Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, et alConsensus Group of the International Society for Premenstrual Disorders. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health 2013;16:279-91.
36. Rapkin AJ, Mikacich JA. Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents. Paediatr Drugs 2013;15:191-202.
37. Najafi M, Sadeghi MM, Mehvari J, Zare M, Akbari M. Progesterone therapy in women with intractable catamenial epilepsy. Adv Biomed Res 2013;2:8.
38. Reddy DS. Clinical pharmacokinetic interactions between anti-epileptic drugs and hormonal contraceptives. Expert Rev Clin Pharmacol 2010;3:183-92.
39. Lohiya GS, Tan-Figueroa L, Silverman S, Le HV. The wheelchair thrombosis syndrome. J Natl Med Assoc 2006;98:1188-92.
40. American College of Obstetricians and Gynecologists. Use of hormonal contraception in women with coexisting medical conditions. ACOG Practice Bulletin No. 73. Obstet Gynecol 2006; 107: 1453-72.
41. Reproductive healthcare for women with disabilities. Interactive public site for clinicians taking care of women with disabilities. 2011. Available at http://streaming.acog.org/WomenWithDisabilities/. Retrieved December 20, 2013.